Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
Global Heart · 2023
DOI: 10.5334/gh.1185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Heart, 2023. Verfasst von Jialun Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Beijing Anzhen Hospital, Beijing, China. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Beijing Anzhen Hospital, Beijing, China.
- School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
- Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
- Department of Pharmacy, Wenzhou Central Hospital, Wenzhou, China.
- Department of Pharmacy, Shougang Hospital, Health Science Centre, Peking University, Beijing, China.
ORCID-Profile: Jialun Han, Yang Lin
Zitieren
APA
Han, J., Zhang, Y., Shi, X., Lin, B., Zhang, Y., Zhang, R., Wang, Y., Yan, J., & Lin, Y. (2023). Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients. Global Heart. https://doi.org/10.5334/gh.1185
Vancouver
Han J, Zhang Y, Shi X, Lin B, Zhang Y, Zhang R, et al. Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients. Global Heart. 2023. doi:10.5334/gh.1185
BibTeX
@article{Han2023,
author = {Han, Jialun and Zhang, Yi and Shi, Xiujin and Lin, Baidi and Zhang, Yunnan and Zhang, Ru and Wang, Yifan and Yan, Jialin and Lin, Yang},
title = {Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients},
journal = {Global Heart},
year = {2023},
doi = {10.5334/gh.1185}
}
EUVIMED